Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic models. (2016)
Attributed to:
Rare disease use of clinical trial simulation for the chioce and optimization of study designs/Priomedchild Call/ER
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/jphp.12618
PubMed Identifier: 27781273
Publication URI: http://europepmc.org/abstract/MED/27781273
Type: Journal Article/Review
Volume: 68
Parent Publication: The Journal of pharmacy and pharmacology
Issue: 12
ISSN: 0022-3573